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Background
To evaluate the efficacy of galantamine-escitalopram
combination in patients with Mild Cognitive Disorder
and Depression. So there is a possible relation between
the deficit of cerebral oxygenation and depression or
relation between the serotonin system and cholinergic
system in relation with disease comorbidity cognitive-
depression.
Objective
To evaluate the therapeutic response in patients with
comorbility between Mild Cognitive Disorder and
Depression in treatment with Galantamine, Escitalopram
and the two drugs in combination.
Materials and methods
A group of 300 patients with symptoms of Mild Cogni-
tive Disorder and Depression (DSM IV-R criteria) were
separated in 3 groups of 100 patients. Each group
received different treatment in an 8 months period:
Group 1: Galantamine 16 mg/day.
Group 2: Escitalopram 20 mg/day.
Group 3: both drugs, same dose.
Results
The therapeutic response evaluated in Hamilton Scale
for Depression(HAM-D), Montgomery and Äsberg
Depression Rating Scale (M.A.D.R.S. ), Mini Mental
State Examination (M.M.S.E.) and Global Clinical
Impression (G.C.I.) scores during 8 months. In the third
group who received the two drugs associated, had much
better response than the others and “brain enhancer”.
Conclusions
The group who received the combination of the nootro-
pic agent Galantamine with antidepressant (SSRIs) Esci-
talopram had a relevant satisfactory therapeutic
response (the best result), so there is a possible relation
between the deficit in cholinergic systems and depres-
sion. Could be cerebral cholinergic systems deficit a
generator of Depressive Disorder?
Attention and memory functions are closely tied to
the cholinergic neurotransmitter system. The cholinergic
system is one of the neurotransmitter systems impli-
cated in the pathophysiology of mood disorders.
Evidence suggests that during major depressive episodes,
the cholinergic system is hypersensitive to acetylcholine.
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